Spontaneous Preterm Birth and Related Obstetric Syndromes: Integrating Genetic Mechanisms, Cervical Biology, Precision Diagnostics, Clinical Prediction, and Preventive Strategies

Sonographic cervical length is one of the strongest predictors of spontaneous preterm birth, yet the biological mechanisms governing cervical remodeling across pregnancy have remained incompletely understood. In a large prospective longitudinal cohort of more than 5,000 Black/African American women with serial cervical length measurements and genome-wide genotyping, we investigated the genetic architecture of cervical length dynamics and their relationship with gestational duration.

Using latent growth-curve modeling integrated with genome-wide complex trait analysis, we demonstrated that cervical remodeling across pregnancy is highly heritable, with genetic factors accounting for approximately half of the observed inter-individual variability. Strong genetic correlations between cervical length trajectories and gestational duration indicate that a substantial proportion of genetic risk for spontaneous preterm birth is mediated through biological pathways regulating cervical shortening and effacement.

Genetic loci associated with cervical remodeling were enriched in pathways central to pregnancy maintenance and parturition, including progesterone and estrogen signaling, immune and inflammatory responses, and extracellular matrix organization. These findings establish cervical remodeling as a biologically active, genetically regulated intermediate phenotype linking maternal genetic risk to spontaneous preterm birth, and they provide a framework for integrating genetic information with longitudinal cervical assessment to improve risk prediction and prevention strategies.

Vaginal progesterone is a cornerstone intervention for the prevention of spontaneous preterm birth in pregnancies at increased risk because of a sonographic short cervix. Through a comprehensive program of research, including updated individual patient data meta-analyses, subgroup analyses, and long-term follow-up studies, we evaluated both the efficacy and safety of vaginal progesterone across diverse clinical populations.

In singleton pregnancies with a mid-trimester transvaginal cervical length less than or equal to 25 mm, vaginal progesterone significantly reduced the risk of early preterm birth across several gestational age thresholds and was associated with reductions in major neonatal morbidity, including respiratory distress syndrome and very low birthweight. Importantly, benefit was observed in women both with and without a prior history of spontaneous preterm birth, resolving a key area of clinical uncertainty and reinforcing the value of universal cervical-length screening followed by targeted treatment.

In selected twin pregnancies with a short cervix, vaginal progesterone also reduced early preterm birth and adverse perinatal outcomes, despite the absence of benefit in unselected twin populations. Long-term follow-up of exposed offspring demonstrated no adverse cognitive, behavioral, or psychopathological effects at six to nine years of age, providing critical reassurance regarding neuro-developmental safety. Together, these studies have directly informed international clinical guidelines and strengthened evidence-based strategies to reduce the global burden of preterm birth.

Intra-amniotic infection is a major cause of spontaneous preterm labor and preterm, pre-labor rupture of membranes, yet diagnosis is often delayed by the limitations of conventional microbiologic methods. In this prospective cohort study, we evaluated the clinical utility of third-generation nanopore sequencing for rapid, species-level identification of microorganisms in amniotic fluid.

Nanopore sequencing enabled real-time detection of bacterial pathogens, including fastidious and polymicrobial infections, with high diagnostic accuracy and substantially faster turnaround than standard culture-based approaches. The quantitative microbial burden measured by sequencing correlated strongly with the intensity of the intra-amniotic inflammatory response, linking molecular findings to biological severity.

This work demonstrates that real-time sequencing technologies can transform the diagnosis of intra-amniotic infection and provides a foundation for precision approaches to antimicrobial therapy, pregnancy management, and prevention of infection-related preterm birth.

For decades, assessment of labor progress has relied on time-based labor curves derived from cervical dilation patterns. Although historically influential, these models have limited prospective utility in contemporary clinical practice. In this study, we evaluated whether multifactor clinical models provide more accurate prediction of labor progress.

Using a large longitudinal dataset of more than 8,000 nulliparous women and nearly 48,000 cervical examinations, we compared traditional time-only models with multifactor models incorporating clinically relevant variables such as cervical dilation, effacement, fetal station, and labor interventions. Multifactor models demonstrated substantially greater accuracy and stability, reducing prediction error by nearly 50% compared with time-based approaches.

These findings support reconceptualizing labor as a dynamic, multifactorial process and highlight the potential of data-driven tools to improve intra-partum decision-making, reduce unnecessary interventions, and enhance maternal and neonatal outcomes.

Late-onset preeclampsia accounts for the majority of preeclampsia cases worldwide, yet reliable biomarkers for prediction and diagnosis remain limited. Using large-scale longitudinal plasma proteomics, we characterized molecular changes preceding the clinical onset of late-onset preeclampsia across gestation.

High-throughput analysis revealed progressively increasing protein dysregulation with advancing pregnancy, particularly in pathways related to angiogenesis, inflammation, and extracellular matrix remodeling. Multiprotein predictive models constructed from these data outperformed established angiogenic biomarkers in late pregnancy, even before clinical disease became apparent.

These findings demonstrate that late-onset preeclampsia is associated with detectable, progressive molecular alterations in maternal circulation and highlight the potential of proteomics-based approaches to improve risk stratification, diagnosis, and clinical management of hypertensive disorders of pregnancy.